A student-run resource for reliable reports on the latest law and technology news

Archive for the ‘Food and Drug Administration’ Category

Flash Digest: News in Brief

By Gia Velasquez – Edited by Olga Slobodyanyuk

The Federal Aviation Association Implements a Mandatory Registration Process for Drones

The FDA Expedites the Review Process for Generic Pharmaceutical Drugs

Senate Rejects GMO Labeling Bill

Read More...

Posted On Mar - 22 - 2016 Add Comments READ FULL POST

Flash Digest: News in Brief

By Mila Owen – Edited by Olga Slobodyanyuk

Senate CISA Debates End

The FDA CDRH released its Regulatory Science Priorities for 2016

Germany requires all Internet companies to make metadata available to its law enforcement agencies

Read More...

Posted On Nov - 4 - 2015 Comments Off READ FULL POST

Illinois District Court Opinion Shows Uncertainty of the Economics of ANDA litigation

By Yaping Zhang – Edited by Mengyi Wang

The Northern District of Illinois just laid down a Hatch-Waxman opinion, holding that the Mylan Pharmaceuticals Inc. infringed the patent No. 727 Patent held by Medicines Company. Patently-O published a study that demonstrates ANDA Paragraph (iv) cases have increasingly settled, reducing consumer surplus. The case suggests that there are potentially more complicated calculus and players embedded in ANDA litigations than originally thought.

Read More...

Posted On Nov - 10 - 2014 Comments Off READ FULL POST

Flash Digest: News In Brief
By James Grace

Hershey’s Opposes Mars’ Attempt to Register a Snickers’ Cross-Section as a Design Mark

Medtronic v. Boston Scientific – Oral Argument

Proposed Tweak to Law Would Pull Shield From Generic-Drug Makers

Read More...

Posted On Nov - 10 - 2013 Comments Off READ FULL POST

Federal Circuit Finds Bayer’s Yaz Birth Control Patent Invalid for Obviousness

Bayer Healthcare Pharm., Inc. v. Watson Pharm., Inc.
By Erica Larson – Edited by Suzanne Van Arsdale

The Court of Appeals for the Federal Circuit reversed the judgment of the Nevada District Court, which ruled that claims 13 and 15 of Bayer Healthcare Pharmaceuticals, Inc. and Bayer Schering Pharma AG (“Bayer”) U.S. Patent RE37,564 were not invalid for obviousness. The patent claimed a combination of synthetic hormones and dosing regimens used by Bayer in the Yaz birth control pill.

Read More...

Posted On Apr - 30 - 2013 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
Unknown

Insuring Patents

By Yaping Zhang Edited by Jennifer Chung and Ariel Simms Despite its ...

Senate Judiciary Committee

Defend Trade Secrets

By Suyoung Jang – Edited by Mila Owen S.1890 - Defend ...

Flash Digest

Federal Circuit Flas

By Evan Tallmadge – Edited by Olga Slobodyanyuk The Linked Inheritability ...

Illinois Flag

Amicus Brief by EFF

By Yaping Zhang – Edited by Mila Owen On April 6, ...

Fed. Cir. Flash Digest

Flash Digest: News i

By Gia Velasquez – Edited by Ken Winterbottom Federal Court Grants ...